MEDNAX (MD) Misses Q3 EPS by 2c, Guides Q4 EPS Below the Street

MEDNAX (NYSE: MD) reported Q3 EPS of $1.09, $0.02 worse than the analyst estimate of $1.11. Revenue for the quarter came in at $828 million versus the consensus estimate of $821.18 million.

GUIDANCE:

MEDNAX sees Q4 2016 EPS of $1.04-$1.08, versus the consensus of $1.13.

For earnings history and earnings-related data on MEDNAX (MD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c